BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

616 hedge funds and large institutions have $1.57B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 616 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
616
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$48M
Puts
$8.03M
Net Calls
Net Calls Change

Top Buyers

1
+$150M
2
+$107M
3
+$91.4M
4
Viking Global Investors
Viking Global Investors
Connecticut
+$78.3M
5
ACM
Abrams Capital Management
Massachusetts
+$69.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
176
$419K
177
$412K
178
$408K
179
$402K
180
$389K
181
$386K
182
$381K
183
$374K
184
$366K
185
$364K
186
$359K
187
$357K
188
$356K
189
$356K
190
$355K
191
$353K
192
$350K
193
$346K
194
$342K
195
$337K
196
$336K
197
$325K
198
$316K
199
$316K
200
$314K
6 7
8
9 10